Los Angeles Capital Management LLC Celldex Therapeutics, Inc. Transaction History
Los Angeles Capital Management LLC
- $24.7 Billion
- Q3 2024
A detailed history of Los Angeles Capital Management LLC transactions in Celldex Therapeutics, Inc. stock. As of the latest transaction made, Los Angeles Capital Management LLC holds 6,738 shares of CLDX stock, worth $165,013. This represents 0.0% of its overall portfolio holdings.
Number of Shares
6,738
Previous 7,371
8.59%
Holding current value
$165,013
Previous $272,000
16.18%
% of portfolio
0.0%
Previous 0.0%
Shares
5 transactions
Others Institutions Holding CLDX
# of Institutions
199Shares Held
65.9MCall Options Held
1.68MPut Options Held
980K-
Wellington Management Group LLP Boston, MA9.24MShares$226 Million0.06% of portfolio
-
Black Rock Inc. New York, NY4.69MShares$115 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA3.87MShares$94.8 Million0.0% of portfolio
-
Kynam Capital Management, LP Princeton, NJ3.46MShares$84.7 Million9.64% of portfolio
-
Eventide Asset Management, LLC Boston, MA3.33MShares$81.6 Million1.99% of portfolio
About Celldex Therapeutics, Inc.
- Ticker CLDX
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 46,772,400
- Market Cap $1.15B
- Description
- Celldex Therapeutics, Inc., a biopharmaceutical company, engages in developing therapeutic monoclonal and bispecific antibodies for the treatment of various diseases. Its drug candidates include antibody-based therapeutics to treat patients with inflammatory diseases and various forms of cancer. The company's clinical development programs CDX-01...